3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
52
Ovarian Neoplasms
40
Multiple Myeloma
20
Fallopian Tube Neoplasms
13
Lymphoma
12
Sarcoma
11
Carcinoma, Ovarian Epithelial
11
Triple Negative Breast Neoplasms
8
Recurrence
8
Lymphoma, Large B-Cell, Diffuse
8
Neoplasms
7
Lymphoma, Non-Hodgkin
7
Hodgkin Disease
6
Neoplasms, Plasma Cell
5
Sarcoma, Ewing
4
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Lymphoma, Mantle-Cell
4
Burkitt Lymphoma
4
Rhabdomyosarcoma
3
Osteosarcoma
3
Lymphoma, T-Cell, Peripheral
3
Leiomyosarcoma
3
Breast Neoplasms, Male
3
Uterine Cervical Neoplasms
2
Solid Tumors
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, T-Cell
2
Interventions
Surgical Procedures, Operative
2
Paclitaxel
2
Doxorubicin
2
Cyclophosphamide
2
Carboplatin
2
pertuzumab
1
liposomal doxorubicin
1
cemiplimab
1
atezolizumab
1
Trastuzumab
1
Radiotherapy
1
Magnetic Resonance Spectroscopy
1
Indocyanine Green
1
Anastrozole
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Invasive Breast Cancer
×
liposomal doxorubicin
×
Clear all
NCT04243616
2025-09-05
CemiHALT
Medical College of Wisconsin
Phase 2
Active not recruiting
36 enrolled